Abstract
The human brain requires adequate cerebral blood flow to meet the high demand for nutrients and to clear waste products. With age, there is a chronic reduction in cerebral blood flow in small resistance arteries that can eventually limit proper brain function. The endothelin system is a key mediator in the regulation of cerebral blood flow, but the contributions of its constituent receptors in the endothelial and vascular smooth muscle layers of cerebral arteries have not been well defined in the context of aging. We isolated posterior cerebral arteries from young and aged Fischer 344 rats, as well as ETB receptor knock-out rats and mounted the vessels in plexiglass pressure myograph chambers to measure myogenic tone in response to increasing pressure and targeted pharmacological treatments. We used an ETA receptor antagonist (BQ-123), an ETB receptor antagonist (BQ-788), endothelin-1, an endothelin-1 synthesis inhibitor (phosphoramidon), and vessel denudation to dissect the roles of each receptor in aging vasculature. Aged rats exhibited a higher myogenic tone than young rats, and the tone was sensitive to the ETA antagonist, BQ-123, but insensitive to the ETB antagonist, BQ-788. By contrast, the tone in the vessels from young rats was raised by BQ-788 but unaffected by BQ-123. When the endothelial layer that is normally enriched with ETB1 receptors was removed from young vessels, myogenic tone increased. However, denudation of the endothelial layer did not influence vessels from aged animals. This indicated that endothelial ETB1 receptors were not functional in the vessels from aged rats. There was also an increase in ETA receptor expression with age, whereas ETB receptor expression remained constant between young and aged animals. These results demonstrate that in young vessels, ETB1 receptors maintain a lower myogenic tone, but in aged vessels, a loss of ETB receptor activity allows ETA receptors in vascular smooth muscle cells to raise myogenic tone. Our findings have potentially important clinical implications for treatments to improve cerebral perfusion in older adults with diseases characterized by reduced cerebral blood flow.
Similar content being viewed by others
References
Aanerud J, Borghammer P, Rodell A, Jónsdottir KY, Gjedde A. Sex differences of human cortical blood flow and energy metabolism. J Cereb Blood Flow Metab. 2017;37:2433–40. https://doi.org/10.1177/0271678X16668536.
Angus JA, Hughes RJA, Wright CE. Distortion of KB estimates of endothelin-1 ETA and ETB receptor antagonists in pulmonary arteries: possible role of an endothelin-1 clearance mechanism. Pharmacol Res Perspect. 2017;5(6):e00374. https://doi.org/10.1002/prp2.374.
Armstead WM. Endothelin-1 contributes to normocapnic hyperoxic pial artery vasoconstriction. Brain Res. 1999;842(1):252–5. https://doi.org/10.1016/s0006-8993(99)01825-9.
Asai K, Kudej RK, Takagi G, Kudej AB, Natividad F, Shen YT, et al. Paradoxically enhanced endothelin-B receptor-mediated vasoconstriction in conscious old monkeys. Circulation. 2001;103:2382–6. https://doi.org/10.1161/01.cir.103.19.2382.
Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001;21:1133–45. https://doi.org/10.1097/00004647-200110000-00001.
Barrett-O’Keefe Z, Ives SJ, Trinity JD, Morgan G, Rossman MJ, Donato AJ, et al. Endothelin-A-mediated vasoconstriction during exercise with advancing age. J Gerontol A Biol Sci Med Sci. 2015;70:554–65. https://doi.org/10.1093/gerona/glu065.
Blackwell KA, Sorenson JP, Richardson DM, Smith LA, Suda O, Nath K, et al. Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol. 2004;287:H2448–53. https://doi.org/10.1152/ajpheart.00248.2004.
Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–6. https://doi.org/10.1016/0735-1097(94)90305-0.
Chen JJ, Rosas HD, Salat DH. Age-associated reductions in cerebral blood flow are independent from regional atrophy. Neuroimage. 2011;55:468–78. https://doi.org/10.1016/j.neuroimage.2010.12.032.
Cifuentes EG, Hornick MG, Havalad S, Donovan RL, Gulati A. Neuroprotective effect of IRL-1620, an endothelin B receptor agonist, on a pediatric rat model of middle cerebral artery occlusion. Front Pediatr. 2018;6. https://doi.org/10.3389/fped.2018.00310.
Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol. 2011;165(5):687–701. https://doi.org/10.1530/EJE-11-0447.
Cramer H, Müller-Esterl W, Schroeder C. Subtype-specific desensitization of human endothelin ETA and ETB receptors reflects differential receptor phosphorylation. Biochemistry. 1997;36:13325–32. https://doi.org/10.1021/bi9708848.
Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002;90:1159–66. https://doi.org/10.1161/01.res.0000020401.61826.ea.
Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, et al. Endothelin. Pharmacol Rev. 2016;68:357–418. https://doi.org/10.1124/pr.115.011833.
Davenport AP, O’Reilly G, Kuc RE. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Br J Pharmacol. 1995;114:1110–6. https://doi.org/10.1111/j.1476-5381.1995.tb13322.x.
Diaz-Otero JM, Garver H, Fink GD, Jackson WF, Dorrance AM. Aging is associated with changes to the biomechanical properties of the posterior cerebral artery and parenchymal arterioles. Am J Physiol Heart Circ Physiol. 2016;310:H365–75. https://doi.org/10.1152/ajpheart.00562.2015.
Donato AJ, Lesniewski LA, Delp MD. The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles. Cardiovasc Res. 2005;66:393–401. https://doi.org/10.1016/j.cardiores.2004.10.023.
Donato AJ, Gano LB, Eskurza I, Silver AE, Gates PE, Jablonski K, et al. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2009;297:H425–32. https://doi.org/10.1152/ajpheart.00689.2008.
D’Orléans-Juste P, Plante M, Honoré JC, Carrier E, Labonté J. Synthesis and degradation of endothelin-1. Can J Physiol Pharmacol. 2003;81(6):503–10. https://doi.org/10.1139/y03-032.
Durand MJ, Phillips SA, Widlansky ME, Otterson MF, Gutterman DD. The vascular renin-angiotensin system contributes to blunted vasodilation induced by transient high pressure in human adipose microvessels. Am J Physiol Heart Circ Physiol. 2014;307(1):H25–32. https://doi.org/10.1152/ajpheart.00055.2014.
Elisa T, Antonio P, Giuseppe P, Alessandro B, Giuseppe A, Federico C, et al. Endothelin receptors expressed by immune cells are involved in modulation of inflammation and in fibrosis: relevance to the pathogenesis of systemic sclerosis, vol. 147616; 2015. p. 1–11. https://doi.org/10.1155/2015/147616.
Elshourbagy NA, Adamou JE, Gagnon AW, Wu H-L, Pullen M, Nambi P. Molecular characterization of a novel human endothelin receptor splice variant. J Biol Chem. 1996;271:25300–7. https://doi.org/10.1074/jbc.271.41.25300.
Esposito G, Van Horn JD, Weinberger DR, Berman KF. Gender differences in cerebral blood flow as a function of cognitive state with PET. J Nucl Med. 1996;37:559–64.
Feger GI, Schilling L, Ehrenreich H, Wahl M. Endothelium-dependent relaxation counteracting the contractile action of endothelin-1 is partly due to ETB receptor activation. Res Exp Med (Berl). 1997;196(6):327–37. https://doi.org/10.1007/BF02576857.
Frommer KW, Müller-Ladner U. Expression and function of ETA and ETB receptors in SSc. Rheumatology. 2008;47:v27–8. https://doi.org/10.1093/rheumatology/ken274.
Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–6. https://doi.org/10.1038/288373a0.
Gariepy CE, Cass DT, Yanagisawa M. Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc Natl Acad Sci U S A. 1996;93:867–72. https://doi.org/10.1073/pnas.93.2.867.
Gendron ME, Thorin E. A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in mice. Am J Physiol Heart Circ Physiol. 2007;293:H2508–15. https://doi.org/10.1152/ajpheart.00352.2007.
Girouard H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol. 2006;100:328–35. https://doi.org/10.1152/japplphysiol.00966.2005.
Gulati A, Hornick MG, Briyal S, Lavhale MS. A novel neuroregenerative approach using ET(B) receptor agonist, IRL-1620, to treat CNS disorders. Physiol Res. 2018;67:S95–S113. https://doi.org/10.33549/physiolres.933859.
Gur RE, Gur RC. Gender differences in regional cerebral blood flow. Schizophr Bull. 1990;16:247–54. https://doi.org/10.1093/schbul/16.2.247.
Hachinski V. Dementia: paradigm shifting into high gear. Alzheimers Dement. 2019;15:985–94. https://doi.org/10.1016/j.jalz.2019.01.006.
Hamner JW, Tan CO. Relative contributions of sympathetic, cholinergic, and myogenic mechanisms to cerebral autoregulation. Stroke. 2014;45:1771–7. https://doi.org/10.1161/STROKEAHA.114.005293.
Ho W-SV, Hiley CR. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br J Pharmacol. 2003;138:1320–32. https://doi.org/10.1038/sj.bjp.0705160.
Holmboe SA, Skakkebæk NE, Juul A, Scheike T, Jensen TK, Linneberg A, et al. Individual testosterone decline and future mortality risk in men. Eur J Endocrinol. 2018;178(1):123–30. https://doi.org/10.1530/EJE-17-0280.
Johansson B. Myogenic tone and reactivity: definitions based on muscle physiology. J Hypertens. 1989;7:S5–8 discussion S9.
Kalaria RN. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev. 2010;68:S74–87. https://doi.org/10.1111/j.1753-4887.2010.00352.x.
Karaki H, Sudjarwo SA, Hori M. Novel antagonist of endothelin ETB1 and ETB2 receptors, BQ-788: effects on blood vessel and small intestine. Biochem Biophys Res Commun. 1994;205:168–73. https://doi.org/10.1006/bbrc.1994.2645.
Karaki H, Sudjarwo SA, Hori M, Sakata K, Urade Y, Takai M, et al. ETB receptor antagonist, IRL 1038, selectively inhibits the endothelin-induced endothelium-dependent vascular relaxation. Eur J Pharmacol. 1993;231:371–4. https://doi.org/10.1016/0014-2999(93)90112-u.
Karet FE, Kuc RE, Davenport AP. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int. 1993;44:36–42. https://doi.org/10.1038/ki.1993.210.
Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation. 2007;116(23):2694–701. https://doi.org/10.1161/CIRCULATIONAHA.107.719005.
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412. https://doi.org/10.1371/journal.pbio.1000412.
Krishnamoorthy RR, Rao VR, Dauphin R, Prasanna G, Johnson C, Yorio T. Role of the ETB receptor in retinal ganglion cell death in glaucoma. Can J Physiol Pharmacol. 2008;86:380–93. https://doi.org/10.1139/Y08-040.
Kukull WA, Ganguli M. Epidemiology of dementia: concepts and overview. Neurol Clin. 2000;18:923–50. https://doi.org/10.1016/s0733-8619(05)70233-4.
Küng CF, Lüscher TF. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension. 1995;25:194–200. https://doi.org/10.1161/01.hyp.25.2.194.
Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 2008;93(1):68–75. https://doi.org/10.1210/jc.2007-1792.
Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJ, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain. 1990;113(Pt 1):27–47. https://doi.org/10.1093/brain/113.1.27.
MacIntyre JN, Slusar JE, Zhu J, Dong AX, Howlett SE, Kelly ME. Age-associated alterations in retinal arteriole reactivity to endothelin-1 differ between the sexes. Mech Ageing Dev. 2012;133(9-10):611–9. https://doi.org/10.1016/j.mad.2012.08.001.
Mandalà M, Pedatella AL, Morales Palomares S, Cipolla MJ, Osol G. Maturation is associated with changes in rat cerebral artery structure, biomechanical properties and tone. Acta Physiol. 2012;205:363–71. https://doi.org/10.1111/j.1748-1716.2011.02406.x.
Marchal G, Rioux P, Petit-Taboué MC, Sette G, Travère JM, Le Poec C, et al. Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging. Arch Neurol. 1992;49:1013–20. https://doi.org/10.1001/archneur.1992.00530340029014.
Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M, Morimoto S. Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett. 1990;272(1-2):166–70. https://doi.org/10.1016/0014-5793(90)80475-x.
McCulloch KM, Docherty CC, Morecroft I, MacLean MR. Endothelin B receptor-mediated contraction in human pulmonary resistance arteries. Br J Pharmacol. 1996;119:1125–30. https://doi.org/10.1111/j.1476-5381.1996.tb16013.x.
Mickley EJ, Gray GA, Webb DJ. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries. Br J Pharmacol. 1997;120:1376–82. https://doi.org/10.1038/sj.bjp.0701036.
Moreau KM, Babcock MC, Hildreth KL. Sex differences in vascular aging in response to testosterone. Biol Sex Differ. 2020;11(1):18. https://doi.org/10.1186/s13293-020-00294-8.
Muller-Delp JM, Spier SA, Ramsey MW, Delp MD. Aging impairs endothelium-dependent vasodilation in rat skeletal muscle arterioles. Am J Physiol Heart Circ Physiol. 2002a;283:H1662–72. https://doi.org/10.1152/ajpheart.00004.2002.
Muller-Delp JM, Spier SA, Ramsey MW, Lesniewski LA, Papadopoulos A, Humphrey JD, et al. Effects of aging on vasoconstrictor and mechanical properties of rat skeletal muscle arterioles. Am J Physiol Heart Circ Physiol. 2002b;282:H1843–54. https://doi.org/10.1152/ajpheart.00666.2001.
Nilsson T, Cantera L, Adner M, Edvinsson L. Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery. 1997;40:346–53. https://doi.org/10.1097/0006123-199702000-00023.
Osol G, Laher I, Cipolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res. 1991;68(2):359–67. https://doi.org/10.1161/01.res.68.2.359.
Ozturk ED, Tan CO. Human cerebrovascular function in health and disease: insights from integrative approaches. J Physiol Anthropol. 2018;37:4. https://doi.org/10.1186/s40101-018-0164-z.
Pierre LN, Davenport AP. Blockade and reversal of endothelin-induced constriction in pial arteries from human brain. Stroke. 1999;30:638–43. https://doi.org/10.1161/01.str.30.3.638.
Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev. 1997;77:731–58. https://doi.org/10.1152/physrev.1997.77.3.731.
Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Phys. 1986;250:H1145–9. https://doi.org/10.1152/ajpheart.1986.250.6.H1145.
Russell FD, Davenport AP. Secretory pathways in endothelin synthesis. Br J Pharmacol. 1999;126(2):391–8. https://doi.org/10.1038/sj.bjp.0702315.
Sader MA, Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53:597–604. https://doi.org/10.1016/S0008-6363(01)00473-4
Schiffrin EL, Turgeon A, Deng LY. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Br J Pharmacol. 1997;121:935–40. https://doi.org/10.1038/sj.bjp.0701224.
Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann Neurol. 2002;52:168–74. https://doi.org/10.1002/ana.10265.
Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond). 2011;120(9):357–75. https://doi.org/10.1042/CS30100476.
Shipley RD, Muller-Delp JM. Aging decreases vasoconstrictor responses of coronary resistance arterioles through endothelium-dependent mechanisms. Cardiovasc Res. 2005;66:374–83. https://doi.org/10.1016/j.cardiores.2004.11.005.
Singh N, Prasad S, Singer DRJ, MacAllister RJ. Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm. Clin Sci (Lond). 2002;102:595–600.
Soma S, Takahashi H, Muramatsu M, Oka M, Fukuchi Y. Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. Am J Respir Cell Mol Biol. 1999;20:620–30. https://doi.org/10.1165/ajrcmb.20.4.3356.
Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol Heart Circ Physiol. 2018;315(6):H1569–88. https://doi.org/10.1152/ajpheart.00396.2018.
Sudjarwo SA, Hori M, Tanaka T, Matsuda Y, Okada T, Karaki H. Subtypes of endothelin ETA and ETB receptors mediating venous smooth muscle contraction. Biochem Biophys Res Commun. 1994;200:627–33. https://doi.org/10.1006/bbrc.1994.1494.
Szok D, Hansen-Schwartz J, Edvinsson L. In depth pharmacological characterization of endothelin B receptors in the rat middle cerebral artery. Neurosci Lett. 2001;314:69–72. https://doi.org/10.1016/s0304-3940(01)02293-5.
Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension. 2001;38:274–9. https://doi.org/10.1161/01.hyp.38.2.274.
Takai M, Umemura I, Yamasaki K, Watakabe T, Fujitani Y, Oda K, et al. A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. Biochem Biophys Res Commun. 1992;184:953–9. https://doi.org/10.1016/0006-291x(92)90683-c.
Tanaka T, Tsukuda E, Nozawa M, Nonaka H, Ohno T, Kase H, et al. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin. Mol Pharmacol. 1994:45724–30.
Tang EH, Vanhoutte PM. Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genomics. 2008;32:409–18. https://doi.org/10.1152/physiolgenomics.00136.2007.
Tarumi T, Zhang R. Cerebral blood flow in normal aging adults: cardiovascular determinants, clinical implications, and aerobic fitness. J Neurochem. 2018;144:595–608. https://doi.org/10.1111/jnc.14234.
Thijssen DHJ, Rongen GA, van Dijk A, Smits P, Hopman MTE. Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects. J Appl Physiol. 2007;103:852–7. https://doi.org/10.1152/japplphysiol.00357.2007.
Thorin E, Cernacek P, Dupuis J. Endothelin-1 regulates tone of isolated small arteries in the rat: effect of hyperendothelinemia. Hypertension. 1998;31(4):1035–41. https://doi.org/10.1161/01.hyp.31.4.1035.
Tokunaga O, Fan J, Watanabe T, Kobayashi M, Kumazaki T, Mitsui Y. Endothelin. Immunohistologic localization in aorta and biosynthesis by cultured human aortic endothelial cells. Lab Investig. 1992;67:210–7.
Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123:849–67. https://doi.org/10.1161/CIRCRESAHA.118.311378.
Van Guilder GP, Westby CM, Greiner JJ, Stauffer BL, DeSouza CA. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension. 2007;50:403–9. https://doi.org/10.1161/HYPERTENSIONAHA.107.088294.
Ward ME, Yan L, Kelly S, Angle MR. Flow modulation of pressure-sensitive tone in rat pial arterioles: role of the endothelium. Anesthesiology. 2000;93(6):1456–64. https://doi.org/10.1097/00000542-200012000-00018.
Ward ME, Yan L, Angle MR. Modulation of rat pial arteriolar responses to flow by glucose. Anesthesiology. 2002;97(2):471–7. https://doi.org/10.1097/00000542-200208000-00026.
Williams LR, Leggett RW. Reference values for resting blood flow to organs of man. Clin Phys Physiol Meas. 1989;10:187–217. https://doi.org/10.1088/0143-0815/10/3/001.
Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, et al. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell. 1994;78(3):473–85. https://doi.org/10.1016/0092-8674(94)90425-1.
Xu X, Wang B, Ren C, Hu J, Greenberg DA, Chen T, et al. Age-related impairment of vascular structure and functions. Aging Dis. 2017;8:590–610. https://doi.org/10.14336/AD.2017.0430.
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411–5. https://doi.org/10.1038/332411a0.
Yao H, Sadoshima S, Ooboshi H, Sato Y, Uchimura H, Fujishima M. Age-related vulnerability to cerebral ischemia in spontaneously hypertensive rats. Stroke. 1991;22:1414–8. https://doi.org/10.1161/01.str.22.11.1414.
Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain. 2012;135:3749–56. https://doi.org/10.1093/brain/aws271.
Yu JC, Pickard JD, Davenport AP. Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells. Br J Pharmacol. 1995;116:2441–6. https://doi.org/10.1111/j.1476-5381.1995.tb15093.x.
Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H, Eng K, et al. Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Cancer. 2000;85(2):281–8. https://doi.org/10.1002/(sici)1097-0215(20000115)85:2<281::aid-ijc21>3.0.co;2-3.
Acknowledgments
The authors acknowledge Adel Zrein and Peter Nicholl for technical assistance.
Funding
This work was funded by a Heart and Stroke Foundation grant to SEH (grant number: G-19-002626), and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (grant number: 05162-2014) to MEMK.
Author information
Authors and Affiliations
Contributions
MEMK, EMDW, and SEH designed the experiments. JZ and AMB performed the experiments. APY analyzed the data and made the figures. APY wrote the manuscript. All authors commented on and approved the final manuscript.
Corresponding author
Ethics declarations
The animal protocols in this study conformed to the guidelines of the Canadian Council on Animal Care and were approved by the Dalhousie University Committee on Laboratory Animals.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 1309 kb)
About this article
Cite this article
Young, A.P., Zhu, J., Bagher, A.M. et al. Endothelin B receptor dysfunction mediates elevated myogenic tone in cerebral arteries from aged male Fischer 344 rats. GeroScience 43, 1447–1463 (2021). https://doi.org/10.1007/s11357-020-00309-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-020-00309-7